Stada and Xbrane Add Two To Biosimilar Development Alliance

 
• By Aidan Fry
Sum
Stada and Xbrane have added certolizumab and nivolumab to their existing biosimilar alliance covering ranibizumab • Source: Shutterstock

More from Deals

More from Business